COMPOUND OYSTER PEPTIDE (COMPOUND OYSTER PEPTIDE)
**Product type:** Human Otc Drug
**Active ingredient:** ASIAN GINSENG; CORNUS OFFICINALIS WHOLE; DIOSCOREA CAYENENSIS TUBER; LICORICE; LYCIUM CHINENSE FRUIT; OYSTER, UNSPECIFIED; PHYLLOLOBIUM CHINENSE SEED; POLYGONATUM SIBIRICUM WHOLE; RIBOFLAVIN; SEA CUCUMBER, UNSPECIFIED; TAURINE; THIAMINE; WHITE MULBERRY; ZINC LACTATE
**Strength:** 180; 180; 96; 24; 270; 12; 72; 90; .24; 120; 30; .6; 72; 5.16 mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Bispit Canada Ltd.
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]
/api/v1/systems/ndc_fda/nodes/85631-004Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.